Findings

What do systematic reviews say?

5 questions · 5 findings · 1 reviews

No studies found 1 · 20%GRADE not reported 0 · 0%Very low 4 · 80%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Clinical pregnancy · subfertile women with polycystic ovary syndrome

It is very uncertain whether myo‐inositol changes clinical pregnancy compared with D‐chiro‐inositol (very low certainty).

1 finding from 1 review

Inositol for subfertile women with polycystic ovary syndrome 2018 · Cochrane Headline outcomes only
OR 3.86 [1.25, 11.89]
1 study · 84 participants
Very low

Clinical pregnancy · subfertile women with polycystic ovary syndrome

It is very uncertain whether myo‐inositol changes clinical pregnancy compared with an insulin‐sensitising agent (metformin) (very low certainty).

1 finding from 1 review

Inositol for subfertile women with polycystic ovary syndrome 2018 · Cochrane Headline outcomes only
OR 1.91 [0.81, 4.49]
1 study · 120 participants
Very low

Clinical pregnancy · subfertile women with polycystic ovary syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Inositol for subfertile women with polycystic ovary syndrome 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Clinical pregnancy · subfertile women with polycystic ovary syndrome

It is very uncertain whether myo‐inositol changes clinical pregnancy compared with placebo, no/standard treatment (very low certainty).

1 finding from 1 review

Inositol for subfertile women with polycystic ovary syndrome 2018 · Cochrane Headline outcomes only
OR 1.27 [0.87, 1.85]
4 studies · 535 participants
Very low

Clinical pregnancy · subfertile women with polycystic ovary syndrome

It is very uncertain whether myo‐inositol changes clinical pregnancy compared with antioxidant (melatonin) (very low certainty).

1 finding from 1 review

Inositol for subfertile women with polycystic ovary syndrome 2018 · Cochrane Headline outcomes only
OR 0.83 [0.53, 1.28]
1 study · 358 participants
Very low